---
title: "I need to conduct a meta-analysis of randomized controlled trials examining cognitive behavioral therapy for depression. Guide me through: 1) Determining eligibility criteria and extracting effect sizes from studies"
description: "AI model comparison: I need to conduct a meta-analysis of randomized controlled trials examining cognitive behavioral the..."
date: 2025-10-15
category: comparison
layout: Clean
tags:
  - Grok
  - Mistral
  - AI Comparison
author: SNEOS Community
head:
  - - meta
    - name: description
      content: "AI model comparison: I need to conduct a meta-analysis of randomized controlled trials examining cognitive behavioral therapy for depression...."
---

<ChatComparison
  title="I need to conduct a meta-analysis of randomized controlled trials examining cognitive behavioral therapy for depression. Guide me through: 1) Determining eligibility criteria and extracting effect sizes from studies"
  prompt="I need to conduct a meta-analysis of randomized controlled trials examining cognitive behavioral therapy for depression. Guide me through: 1) Determining eligibility criteria and extracting effect sizes from studies"
  :responses='{"Grok": "### 1. Determining Eligibility Criteria\n\nEligibility criteria ensure only relevant, high-quality randomized controlled trials (RCTs) are included in your meta-analysis of cognitive behavioral therapy (CBT) for depression. These criteria should be predefined in a protocol (e.g., following PRISMA or Cochrane guidelines) to minimize bias. Here\u0027s a step-by-step guide to defining them:\n\n#### Step 1: Establish Inclusion Criteria\n- **Population**: Focus on adults (or specify age groups, e.g., 18\u002B) diagnosed with depression. Use standardized criteria like DSM-5/ICD-11 major depressive disorder, or validated scales (e.g., Hamilton Depression Rating Scale score \u226517). Exclude comorbidities if they confound results (e.g., bipolar disorder unless specified).\n- **Intervention**: Trials where CBT is the primary intervention (individual, group, or online formats). Specify duration (e.g., at least 8 sessions) and compare to control conditions like waitlist, treatment as usual (TAU), or active treatments (e.g., pharmacotherapy).\n- **Comparison**: Active controls, placebo, or no treatment to assess CBT\u0027s efficacy.\n- **Outcomes**: Primary: Depression symptom reduction (e.g., via Beck Depression Inventory [BDI] or Patient Health Questionnaire-9 [PHQ-9]). Secondary: Remission rates, quality of life, or relapse prevention.\n- **Study Design**: Only RCTs with random allocation to groups. Quasi-experimental or non-randomized studies are ineligible.\n- **Publication Status**: Include published and unpublished trials (e.g., gray literature) to reduce publication bias. No language restrictions if feasible, but prioritize English for practicality.\n- **Time Frame**: Studies from a specific period (e.g., 1980\u2013present) to capture CBT\u0027s evolution.\n\n#### Step 2: Define Exclusion Criteria\n- Non-RCT designs (e.g., cohort studies, case series).\n- Samples not primarily depressed (e.g., anxiety disorders as primary).\n- CBT combined inseparably with other therapies (e.g., CBT \u002B mindfulness unless you plan a subgroup analysis).\n- Short-term follow-up only (e.g., \u003C6 weeks post-treatment) if your focus is long-term effects.\n- Duplicate publications or subsets of larger trials.\n\n#### Step 3: Operationalize and Document\n- Use a PICO framework (Population, Intervention, Comparison, Outcome) to structure criteria.\n- Create a screening form for title/abstract and full-text review (e.g., via tools like Covidence or Rayyan).\n- Involve at least two independent reviewers to resolve disagreements (e.g., via Kappa statistic for inter-rater reliability \u003E0.8).\n- Pilot-test criteria on 10\u201320 studies to refine them.\n\nThis process typically yields a flow diagram (PRISMA-style) tracking screened, included, and excluded studies.\n\n### 2. Extracting Effect Sizes from Studies\n\nEffect sizes quantify CBT\u0027s impact on depression (e.g., how much it reduces symptoms compared to control). Common metrics for continuous outcomes (depression scores) are standardized mean differences (SMD, e.g., Cohen\u0027s d) or Hedges\u0027 g (bias-corrected). For binary outcomes (e.g., remission), use odds ratios (OR) or risk ratios (RR). Follow these steps:\n\n#### Step 1: Data Extraction Protocol\n- **Team and Tools**: Have two reviewers extract data independently into a spreadsheet (e.g., Excel or Google Sheets) or software like RevMan/Comprehensive Meta-Analysis. Reconcile discrepancies.\n- **Key Data Fields**:\n  - Study details: Authors, year, sample size (n per group), demographics (age, sex, baseline severity).\n  - Intervention: CBT type, duration, fidelity checks.\n  - Outcomes: Pre- and post-intervention means, SDs, or SEs for depression scales; event rates for binary outcomes; follow-up times.\n  - Quality indicators: Allocation concealment, blinding, attrition rates (use tools like Cochrane Risk of Bias 2).\n\n#### Step 2: Calculate Effect Sizes\n- **For Continuous Outcomes (e.g., Mean Depression Scores)**:\n  - Formula for SMD: \\( d = \\frac{M_1 - M_2}{SD_{pooled}} \\), where \\( M_1 \\) and \\( M_2 \\) are intervention/control means, and \\( SD_{pooled} = \\sqrt{\\frac{(n_1-1)SD_1^2 \u002B (n_2-1)SD_2^2}{n_1 \u002B n_2 - 2}} \\).\n  - Use Hedges\u0027 g for small samples: \\( g = d \\times \\left(1 - \\frac{3}{4(n_1 \u002B n_2) - 9}\\right) \\).\n  - If data is missing (e.g., only p-values), impute using formulas or contact authors.\n  - Handle pre-post correlations (assume r=0.5 if unreported) for change scores.\n- **For Binary Outcomes**:\n  - OR = \\( \\frac{(a/c)}{(b/d)} \\), where a=remitted in CBT, b=non-remitted in CBT, c=remitted in control, d=non-remitted in control.\n  - Convert to SMD if mixing with continuous data (e.g., using Chapman\u0027s method).\n- **Software Recommendations**:\n  - Free: R (metafor package) or RevMan for calculations.\n  - Paid: Comprehensive Meta-Analysis or Stata for advanced handling.\n\n#### Step 3: Address Heterogeneity and Issues\n- **Subgroup Analyses**: Extract moderators like CBT format (e.g., online vs. in-person) or depression severity.\n- **Missing Data**: Note and use intention-to-treat (ITT) analyses where possible; sensitivity analyses for imputation.\n- **Effect Size Interpretation**: SMD \u003C0.2=small, 0.5=medium, \u003E0.8=large. Report with 95% CIs.\n- **Quality Check**: Assess for reporting biases (e.g., funnel plots later in meta-analysis).\n\nOnce extracted, you\u0027ll pool effect sizes (e.g., via random-effects model assuming trial heterogeneity). Next steps in a full meta-analysis would include searching databases (PubMed, PsycINFO, Cochrane Library) and assessing heterogeneity (I\u00B2 statistic). If you need guidance on those or software tutorials, let me know!", "Mistral": "Conducting a meta-analysis of randomized controlled trials (RCTs) examining cognitive behavioral therapy (CBT) for depression involves several systematic steps. Here\u2019s a guide to help you determine eligibility criteria and extract effect sizes from studies:\n\n### 1. Determining Eligibility Criteria\n\n#### a. Define the Research Question\nClearly articulate your research question. For example:\n- \u0022What is the effectiveness of CBT compared to other treatments or control conditions in reducing symptoms of depression in adults?\u0022\n\n#### b. Establish Inclusion and Exclusion Criteria\n\n**Inclusion Criteria:**\n1. **Study Design:** Randomized controlled trials (RCTs).\n2. **Population:** Adults (18 years or older) diagnosed with depression.\n3. **Intervention:** Cognitive Behavioral Therapy (CBT).\n4. **Comparison:** Any control condition (e.g., waitlist, treatment as usual, other therapies).\n5. **Outcome:** Measures of depression severity (e.g., Beck Depression Inventory, Hamilton Depression Rating Scale).\n6. **Publication Status:** Published and unpublished studies (to minimize publication bias).\n\n**Exclusion Criteria:**\n1. **Non-RCTs:** Observational studies, case reports, etc.\n2. **Non-CBT Interventions:** Studies using other forms of therapy without a CBT component.\n3. **Non-Depression Populations:** Studies focusing on other mental health conditions without a primary focus on depression.\n4. **Non-Adult Populations:** Studies focusing on children or adolescents.\n\n#### c. Search Strategy\nDevelop a comprehensive search strategy to identify relevant studies. This may include:\n- **Databases:** PubMed, PsycINFO, Embase, Cochrane Library, etc.\n- **Keywords:** \u0022Cognitive Behavioral Therapy,\u0022 \u0022Depression,\u0022 \u0022Randomized Controlled Trial,\u0022 etc.\n- **Time Frame:** Specify the range of publication dates.\n\n### 2. Extracting Effect Sizes from Studies\n\n#### a. Identify Relevant Outcomes\nFocus on the primary outcome measures related to depression severity. Common measures include:\n- Beck Depression Inventory (BDI)\n- Hamilton Depression Rating Scale (HDRS)\n- Patient Health Questionnaire (PHQ-9)\n\n#### b. Extract Data\nFor each eligible study, extract the following data:\n1. **Study Characteristics:**\n   - Author(s)\n   - Year of publication\n   - Sample size\n   - Participant characteristics (age, gender, diagnosis)\n   - Intervention details (type of CBT, duration, frequency)\n   - Comparison condition\n\n2. **Outcome Data:**\n   - Mean and standard deviation (SD) of depression scores at baseline and post-intervention for both the CBT and control groups.\n   - If available, means and SDs at follow-up.\n   - Sample sizes for each group.\n\n#### c. Calculate Effect Sizes\nThe most common effect size for continuous outcomes in RCTs is the standardized mean difference (SMD), also known as Cohen\u2019s d.\n\n**Formula for SMD:**\n\\[ \\text{SMD} = \\frac{M_1 - M_2}{SD_{\\text{pooled}}} \\]\n\nWhere:\n- \\( M_1 \\) is the mean of the CBT group.\n- \\( M_2 \\) is the mean of the control group.\n- \\( SD_{\\text{pooled}} \\) is the pooled standard deviation.\n\n**Pooled Standard Deviation:**\n\\[ SD_{\\text{pooled}} = \\sqrt{\\frac{(n_1 - 1)SD_1^2 \u002B (n_2 - 1)SD_2^2}{n_1 \u002B n_2 - 2}} \\]\n\nWhere:\n- \\( n_1 \\) and \\( n_2 \\) are the sample sizes of the CBT and control groups, respectively.\n- \\( SD_1 \\) and \\( SD_2 \\) are the standard deviations of the CBT and control groups, respectively.\n\n#### d. Handle Missing Data\nIf studies do not report means and SDs, consider the following:\n- **Contact Authors:** Request the missing data directly from the study authors.\n- **Impute Data:** Use statistical methods to impute missing data, but be cautious and transparent about this approach.\n- **Exclude Studies:** If data cannot be obtained or imputed, you may need to exclude the study from the meta-analysis.\n\n### 3. Quality Assessment\nAssess the quality of the included studies using tools such as the Cochrane Risk of Bias Tool for Randomized Trials (RoB 2). This helps in evaluating the potential biases in the studies and the overall quality of the evidence.\n\n### 4. Data Synthesis\nUse statistical software (e.g., R, Stata, SPSS) to perform the meta-analysis. Common methods include:\n- **Fixed-Effect Model:** Assumes that all studies share a common effect size.\n- **Random-Effects Model:** Assumes that the true effect size varies across studies.\n\n### 5. Reporting\nFollow the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines to ensure comprehensive and transparent reporting of your meta-analysis.\n\nBy following these steps, you can systematically determine eligibility criteria, extract effect sizes, and conduct a robust meta-analysis of RCTs examining CBT for depression."}' published-date="{DateTime.UtcNow:HH:mm}"
/>

## Analysis

This comparison demonstrates the different approaches each AI model takes when responding to the same prompt. Here are the key differences observed:

### Response Characteristics

**Grok**: Provides a direct response with 108 sentences. 

**Mistral**: Provides a direct response with 67 sentences. 

## Key Takeaways

- Each model brings unique strengths to this type of query
- Response styles vary significantly between models
- Consider your specific use case when choosing between these models

## Try This Comparison Yourself

Want to test these models with your own prompts? Visit [SNEOS.com](https://sneos.com) to compare AI responses side-by-side in real-time.

---

*This comparison was generated using the [SNEOS AI Comparison Tool](https://sneos.com)*
*Published: October 15, 2025 | Models: Grok, Mistral*
